Trafalgar International (GCAN) Shares Outstanding (Diluted) (2022 - 2026)
Trafalgar International (GCAN) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 833.33 Mn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | 944,935.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944,935.00 |
| Dec 31, 2025 | 824,984.00 |
| Sep 30, 2025 | 900,256.00 |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | 910.37 Mn |
| Dec 31, 2024 | 804.64 Mn |
| Sep 30, 2024 | 804.64 Mn |
| Jun 30, 2024 | 804.64 Mn |
| Mar 31, 2024 | 732.64 Mn |
| Dec 31, 2023 | 755.15 Mn |
| Sep 30, 2023 | 766.68 Mn |
| Jun 30, 2023 | 732.64 Mn |
| Mar 31, 2023 | 732.64 Mn |
| Dec 31, 2022 | 587.77 Mn |
| Sep 30, 2022 | 617.92 Mn |
| Jun 30, 2022 | 516.97 Mn |